This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
Dr. Donald Jensen and Dr. Andrew Aronsohn of the University of Chicago Center for Liver Diseases discuss boceprevir and telaprevir, two recently approved therapies for hepatitis C.
No comments:
Post a Comment